Timo Hautala
Impact in
- Infectious Diseases top 5%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
- Genetics top 10%
- Connective tissue disorders research
- Virus-based gene therapy research
Papers in
-
- Viral Infections and Vectors 12
- Viral Infections and Outbreaks Research 6
- Antifungal resistance and susceptibility 4
-
- Porphyrin Metabolism and Disorders 4
- Co-authors
- Kari I. Kivirikko (9 shared papers)Raili Myllylä (9 shared papers)Jari Heikkinen (5 shared papers)Juha Tuukkanen (4 shared papers)Nina Hautala (13 shared papers)Heikki Kauma (13 shared papers)Antti Vaheri (10 shared papers)Olli Vapalahti (9 shared papers)
- Journals
- The Journal of Gene Medicine (4 papers)Genomics (3 papers)Journal of Clinical Immunology (3 papers)Annals of Medicine (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Timo Hautala
48 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 286
- Genetics 290
- Urology 56
- Rheumatology 128
- Clinical Biochemistry 55
Countries citing papers authored by Timo Hautala
This map shows the geographic impact of Timo Hautala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Hautala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Hautala more than expected).
Fields of papers citing papers by Timo Hautala
This network shows the impact of papers produced by Timo Hautala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Hautala. The network helps show where Timo Hautala may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Hautala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 118 | |
| 2 | 1992 | 117 | |
| 3 | 2002 | 75 | |
| 4 | Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome. | 1994 | 59 |
| 5 | 1993 | 58 | |
| 6 | 1994 | 49 | |
| 7 | 1999 | 48 | |
| 8 | 2006 | 29 | |
| 9 | 2010 | 29 | |
| 10 | 2020 | 29 | |
| 11 | 2017 | 27 | |
| 12 | 2010 | 27 | |
| 13 | 2018 | 26 | |
| 14 | 2007 | 26 | |
| 15 | 1992 | 26 | |
| 16 | 2012 | 25 | |
| 17 | 2005 | 25 | |
| 18 | 1998 | 23 | |
| 19 | 2007 | 22 | |
| 20 | 2011 | 20 |
About Timo Hautala
Timo Hautala is a scholar working on Infectious Diseases, Molecular Biology, Genetics, Immunology and Global and Planetary Change, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral Infections and Vectors (12 papers), Fire effects on ecosystems (10 papers), Connective tissue disorders research (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Viral Infections and Outbreaks Research (6 papers), Antifungal resistance and susceptibility (4 papers), Urological Disorders and Treatments (4 papers) and Porphyrin Metabolism and Disorders (4 papers). The work is most often cited by research in Infectious Diseases (286 citations), Genetics (290 citations), Urology (56 citations), Rheumatology (128 citations) and Clinical Biochemistry (55 citations). Timo Hautala has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Kari I. Kivirikko, Raili Myllylä, Jari Heikkinen, Juha Tuukkanen, Nina Hautala, Heikki Kauma, Antti Vaheri, Olli Vapalahti, Thomas B. Shows and Roger L. Eddy. Their work appears in journals such as The Journal of Gene Medicine, Genomics, Journal of Clinical Immunology, Annals of Medicine and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.